chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Adverse drug reaction
Clinical narrative: received the first shot of moderna COVID-19 vaccine and had side effects; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (received the first shot of moderna COVID-19 vaccine and had side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (received the first shot of moderna COVID-19 vaccine and had side effects). At the time of the report, ADVERSE DRUG REACTION (received the first shot of moderna COVID-19 vaccine and had side effects) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: No new information was provided
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Vaccination site erythema, Vaccination site pain
Clinical narrative: dizziness; tchiness on the area of the injection; bump on the injection site; Nausea; Fatigue; redness and soreness at the injection site; redness and soreness at the injection site; skin rash on her left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PRURITUS (tchiness on the area of the injection), VACCINATION SITE PAIN (redness and soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness and soreness at the injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PAIN (redness and soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness and soreness at the injection site). On 19-May-2021, the patient experienced NAUSEA (Nausea) and FATIGUE (Fatigue). On 24-May-2021, the patient experienced VACCINATION SITE PRURITUS (tchiness on the area of the injection) and VACCINATION SITE SWELLING (bump on the injection site). On an unknown date, the patient experienced DIZZINESS (dizziness). On 21-May-2021, NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. At the time of the report, DIZZINESS (dizziness), VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PRURITUS (tchiness on the area of the injection), VACCINATION SITE PAIN (redness and soreness at the injection site), VACCINATION SITE ERYTHEMA (redness and soreness at the injection site) and VACCINATION SITE SWELLING (bump on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: dizziness; tchiness on the area of the injection; bump on the injection site; Nausea; Fatigue; redness and soreness at the injection site; redness and soreness at the injection site; skin rash on her left shoulder; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PRURITUS (tchiness on the area of the injection), VACCINATION SITE PAIN (redness and soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness and soreness at the injection site) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PAIN (redness and soreness at the injection site) and VACCINATION SITE ERYTHEMA (redness and soreness at the injection site). On 19-May-2021, the patient experienced NAUSEA (Nausea) and FATIGUE (Fatigue). On 24-May-2021, the patient experienced VACCINATION SITE PRURITUS (tchiness on the area of the injection) and VACCINATION SITE SWELLING (bump on the injection site). On an unknown date, the patient experienced DIZZINESS (dizziness). On 21-May-2021, NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. At the time of the report, DIZZINESS (dizziness), VACCINATION SITE RASH (skin rash on her left shoulder), VACCINATION SITE PRURITUS (tchiness on the area of the injection), VACCINATION SITE PAIN (redness and soreness at the injection site), VACCINATION SITE ERYTHEMA (redness and soreness at the injection site) and VACCINATION SITE SWELLING (bump on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen cervical lymph nodes on right side; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen cervical lymph nodes on right side) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen cervical lymph nodes on right side). At the time of the report, LYMPHADENOPATHY (Swollen cervical lymph nodes on right side) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-172105 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: For appending non-significant follow-up
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chest pain, Cough, Fatigue, Gait disturbance
Clinical narrative: Chest pain; cough; was feeling very tired; Very weak; Left Arm hurts; Trouble Walking; Slept for 12 hours; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Very weak), PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours) and CHEST PAIN (Chest pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced ASTHENIA (Very weak), PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours) and FATIGUE (was feeling very tired). On an unknown date, the patient experienced CHEST PAIN (Chest pain) and COUGH (cough). At the time of the report, ASTHENIA (Very weak) was resolving and PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours), CHEST PAIN (Chest pain), COUGH (cough) and FATIGUE (was feeling very tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.         Patient was advised by the doctor to drink Diet Mountain Dew for the potassium in it for energy.   This case was linked to IN-MODERNATX, INC.-MOD-2021-064921 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Upon follow-up receipt: Followup information included updated contact info Dose Start date updated, added lab result  new event was added Events outcome was updated from unknown to  resolved except fatigue.; Sender's Comments:  IN-MODERNATX, INC.-MOD-2021-064921:Mother case
Sex: F
Vaccine: COVID19
Symptoms: Hypersomnia, Pain in extremity, SARS-CoV-2 antibody test
Clinical narrative: Chest pain; cough; was feeling very tired; Very weak; Left Arm hurts; Trouble Walking; Slept for 12 hours; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Very weak), PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours) and CHEST PAIN (Chest pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in December 2020. Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) for an unknown indication.   On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced ASTHENIA (Very weak), PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours) and FATIGUE (was feeling very tired). On an unknown date, the patient experienced CHEST PAIN (Chest pain) and COUGH (cough). At the time of the report, ASTHENIA (Very weak) was resolving and PAIN IN EXTREMITY (Left Arm hurts), GAIT DISTURBANCE (Trouble Walking), HYPERSOMNIA (Slept for 12 hours), CHEST PAIN (Chest pain), COUGH (cough) and FATIGUE (was feeling very tired) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.         Patient was advised by the doctor to drink Diet Mountain Dew for the potassium in it for energy.   This case was linked to IN-MODERNATX, INC.-MOD-2021-064921 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Upon follow-up receipt: Followup information included updated contact info Dose Start date updated, added lab result  new event was added Events outcome was updated from unknown to  resolved except fatigue.; Sender's Comments:  IN-MODERNATX, INC.-MOD-2021-064921:Mother case
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was 16 years of age when the vaccine was given; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 003B2A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 26-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given). On 26-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by the reporter.  No treatment medications provided by the reporter.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Pyrexia
Clinical narrative: Not feeling well; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well) and PYREXIA (Fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Ampicillin), Penicillin allergy and Hypertension. Concomitant products included DIPHENHYDRAMINE for Allergy, LOSARTAN for Hypertension, RIVAROXABAN (XARELTO) for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling well) and PYREXIA (Fever). At the time of the report, MALAISE (Not feeling well) and PYREXIA (Fever) had resolved.            No Treatment information was reported.  Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-083625 (Patient Link).
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: patient was 16 years of age when the vaccine was given; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025A21A and 003B2A) for COVID-19 vaccination.     no medical history was provided.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2. On 23-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given). On 23-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient was 16 years of age when the vaccine was given) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication was reported , No treatment medication was reported .   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nasopharyngitis
Clinical narrative: Headache; Muscle pain; joint pain; Cold; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold), FATIGUE (Fatigue), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain). On 14-Apr-2021, the patient experienced HEADACHE (Headache). At the time of the report, NASOPHARYNGITIS (Cold), FATIGUE (Fatigue), HEADACHE (Headache), MYALGIA (Muscle pain) and ARTHRALGIA (joint pain) outcome was unknown.            No treatment medication provided. No concomitant medication provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen cervical lymph nodes on left side; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen cervical lymph nodes on left side) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen cervical lymph nodes on left side). At the time of the report, LYMPHADENOPATHY (Swollen cervical lymph nodes on left side) had not resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.    This case was linked to MOD-2021-171223 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold
Clinical narrative: Feeling so cold; Extreme chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feeling so cold) and CHILLS (Extreme chills) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced FEELING COLD (Feeling so cold) and CHILLS (Extreme chills). At the time of the report, FEELING COLD (Feeling so cold) and CHILLS (Extreme chills) outcome was unknown.            No concomitant medication was reported No treatment medication was reported  Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to MOD-2021-015590, MOD-2021-015590 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore Arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore Arm). At the time of the report, VACCINATION SITE PAIN (Sore Arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. . Treatment medication was not provided by the reporter.
Sex: M
Vaccine: COVID19
Symptoms: Hypersomnia
Clinical narrative: WAS OUT A WHOLE DAY; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (WAS OUT A WHOLE DAY) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (WAS OUT A WHOLE DAY). At the time of the report, HYPERSOMNIA (WAS OUT A WHOLE DAY) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concominant medications were not reported.  Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Cystitis, Lung cyst, Rash
Clinical narrative: cyst on lung; Bladder infection; rash on arm all way to elbow; This spontaneous case was reported by a consumer and describes the occurrence of LUNG CYST (cyst on lung), CYSTITIS (Bladder infection) and RASH (rash on arm all way to elbow) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LUNG CYST (cyst on lung), CYSTITIS (Bladder infection) and RASH (rash on arm all way to elbow). At the time of the report, LUNG CYST (cyst on lung), CYSTITIS (Bladder infection) and RASH (rash on arm all way to elbow) outcome was unknown.            No treatment information was provided by the reporter. No concomitant information was provided by the reporter.    This case was linked to US-MODERNATX, INC.-MOD-2021-075066 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-075066:dose 1 case
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Wrong product administered
Clinical narrative: Wrong vaccine administered; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Wrong vaccine administered). At the time of the report, WRONG PRODUCT ADMINISTERED (Wrong vaccine administered) had resolved.            No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was  not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Pyrexia, Urticaria
Clinical narrative: Rash described as hives; Aches; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Rash described as hives), MYALGIA (Aches), PYREXIA (Fever) and CHILLS (Chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Previously administered products included for Pneumonia: Pneumonia vaccine on 21-Oct-2018, Pneumonia vaccine on 21-Oct-2018, Pneumonia vaccine (Not able to get into any clothes.) on 21-Oct-2018, Pneumonia vaccine on 21-Oct-2018 and Pneumonia vaccine on 21-Oct-2018. Past adverse reactions to the above products included Ache with Pneumonia vaccine; Chills with Pneumonia vaccine; Fever with Pneumonia vaccine; Swelling with Pneumonia vaccine; and Weakness with Pneumonia vaccine. Concurrent medical conditions included Lymphoma, Latex allergy (Blisters, hives and loss of voice), Fragrance sensitivity (loss of voice and tingling tongue) and Chemical sensitivity (Loss of voice ,heart rate increase, tingling tongue and pain in jaws). Concomitant products included AMLODIPINE for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced URTICARIA (Rash described as hives), MYALGIA (Aches), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, URTICARIA (Rash described as hives), MYALGIA (Aches), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Body temperature: 100.3 (High) 100.3 F.         Patient reported that she may have had kidney stones.     This case was linked to MOD-2021-036308 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: This follow-up was received on 25-MAY-2021 which updated patient demographics, historical vaccine  allergic conditions and facility details.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (fever). At the time of the report, PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-May-2021, Body temperature: 102 (High) 102. On an unknown date, Body temperature: 101.4 (High) 101.4.         No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.            Concomitant product record was not provided by the reporter. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Rash, Sleep disorder
Clinical narrative: can't get enough sleep; developed a bad rash on my back, developed a bad rash on my side; have periodic muscle pains; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (can't get enough sleep), RASH (developed a bad rash on my back, developed a bad rash on my side) and MYALGIA (have periodic muscle pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, the patient experienced SLEEP DISORDER (can't get enough sleep), RASH (developed a bad rash on my back, developed a bad rash on my side) and MYALGIA (have periodic muscle pains). At the time of the report, SLEEP DISORDER (can't get enough sleep), RASH (developed a bad rash on my back, developed a bad rash on my side) and MYALGIA (have periodic muscle pains) outcome was unknown.            Concomitant product was not provided by the reporter.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: Positive COVID-19 Diagnosis (PCR); This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID-19 Diagnosis (PCR)) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced COVID-19 (Positive COVID-19 Diagnosis (PCR)). At the time of the report, COVID-19 (Positive COVID-19 Diagnosis (PCR)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-May-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: Follow-up received: Patient's age updated.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: This spontaneous case reported by a pharmacist, describes the occurrence of underdose (some dose leaked out the injection point) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 027C21A) for COVID-19 immunization. No medical history reported. On May 26, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 26, 2021, patient experienced underdose (some dose leaked out the injection point). On May 26, 2021, underdose (some dose leaked out the injection point) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant product use or treatment information.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: Side effects after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (Side effects after the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (Side effects after the vaccine). At the time of the report, ADVERSE EVENT (Side effects after the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Contusion, Vaccination site swelling
Clinical narrative: Bruised arm; Swollen arm; This spontaneous case was reported by a consumer and describes the occurrence of CONTUSION (Bruised arm) and VACCINATION SITE SWELLING (Swollen arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONTUSION (Bruised arm) and VACCINATION SITE SWELLING (Swollen arm). At the time of the report, CONTUSION (Bruised arm) and VACCINATION SITE SWELLING (Swollen arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment information was not provided.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Syringe issue, Underdose
Clinical narrative: Syringe leaked onto patient; Patient given less than a full dose; This spontaneous case was reported by a pharmacist and describes the occurrence of SYRINGE ISSUE (Syringe leaked onto patient) and UNDERDOSE (Patient given less than a full dose) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049C21A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced SYRINGE ISSUE (Syringe leaked onto patient) and UNDERDOSE (Patient given less than a full dose). On 26-May-2021, SYRINGE ISSUE (Syringe leaked onto patient) and UNDERDOSE (Patient given less than a full dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Influenza, Product dose omission issue, Pyrexia
Clinical narrative: Missed second dose of vaccine; Felt like I had flu; Really sick for 7 straight days; Chills; Fever; Vomiting; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 26-May-2021. The most recent information was received on 26-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine), INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills) and PYREXIA (Fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine), INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine) had resolved and INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant product use was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received on 27-May-2021,contains significant information. Added Patient Demographics, Suspect drug details (Onset Date, Route), New Adverse Events are added. On 26-Jul-2021: Significant FU received - Information on dose 2 is updated
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Missed second dose of vaccine; Felt like I had flu; Really sick for 7 straight days; Chills; Fever; Vomiting; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 26-May-2021. The most recent information was received on 26-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine), INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills) and PYREXIA (Fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine), INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed second dose of vaccine) had resolved and INFLUENZA (Felt like I had flu), ILLNESS (Really sick for 7 straight days), CHILLS (Chills), PYREXIA (Fever) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant product use was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-May-2021: Follow-up information received on 27-May-2021,contains significant information. Added Patient Demographics, Suspect drug details (Onset Date, Route), New Adverse Events are added. On 26-Jul-2021: Significant FU received - Information on dose 2 is updated
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Needle issue, Underdose, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: Vaccination site pain/ arm is a bit sore; bleeding vaccination site; did not get the full dose; needle leaked; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Vaccination site pain/ arm is a bit sore), VACCINATION SITE HAEMORRHAGE (bleeding vaccination site), UNDERDOSE (did not get the full dose) and NEEDLE ISSUE (needle leaked) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 06C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain/ arm is a bit sore), VACCINATION SITE HAEMORRHAGE (bleeding vaccination site), UNDERDOSE (did not get the full dose) and NEEDLE ISSUE (needle leaked). At the time of the report, VACCINATION SITE PAIN (Vaccination site pain/ arm is a bit sore) had resolved and VACCINATION SITE HAEMORRHAGE (bleeding vaccination site), UNDERDOSE (did not get the full dose) and NEEDLE ISSUE (needle leaked) outcome was unknown.            Concomitant product use was not provided.  Treatment information was not provided.  On second shot, when needle was pulled out, some bleeding occurred. The person who made the shot, said that there was no actual vaccine leakage, it was just some minor bleeding which the patient dobbed up with a cotton ball.  The second cotton ball applied was just to clean the area better in order for the band-aid to stick better.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Follow up received on 24-JUL-2021 and  contains updated event verbatim to vaccination site pain/ arm is a bit sore (previously reported as vaccination site pain), new event added bleeding vaccination site.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: low grade fever; bad headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) and HEADACHE (bad headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (low grade fever) and HEADACHE (bad headache). At the time of the report, PYREXIA (low grade fever) and HEADACHE (bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Dermal filler injection, Intentional product use issue
Clinical narrative: Patient did not wait the recommended period; Dermal fillers; This spontaneous case was reported by a nurse and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Patient did not wait the recommended period) and DERMAL FILLER INJECTION (Dermal fillers) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in March 2021. Concurrent medical conditions included Drug allergy (MORPHINE).    In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Patient did not wait the recommended period) and DERMAL FILLER INJECTION (Dermal fillers). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Patient did not wait the recommended period) and DERMAL FILLER INJECTION (Dermal fillers) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided.  Treatment information was not  provided A nurse from Emergency care, called and seemed hesitant in providing additional demographic information and only wanted her question answered.  1st dose received: month after having covid infection, Apr,2021 (no specific date provided) Lot#: 043B21A, Expiration: unknown. She stated she is calling about a Spanish speaking patient with a language barrier. The patient had covid this year in March but received her 1st dose in April,2021 and is there today for her 2nd dose and persistent in receiving her 2nd dose. The nurse stated that the patient did not wait the recommended period from covid infection before receiving her 1st dose and stated that her 3 months are not up yet before the vaccination.     The nurse stated that patient has various allergies (morphine) and had dermal fillers but was unable to state whether the dermal fillers were before or after receiving the 1st dose. The nurse stated that she cannot provide any additional information about the patient.     The nurse declined when asked for consent to safety for follow up and did not want information in written form.     Since the patient presented today to receive her 2nd dose, the nurse asked, can the patient get the 2nd dose or does she have to wait?
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue
Clinical narrative: A magnet stuck to the injection site; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (A magnet stuck to the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEVICE CONNECTION ISSUE (A magnet stuck to the injection site). At the time of the report, DEVICE CONNECTION ISSUE (A magnet stuck to the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Tongue dry
Clinical narrative: My tongue has become very dry since I received the first does of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine). At the time of the report, TONGUE DRY (My tongue has become very dry since I received the first does of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Nasopharyngitis
Clinical narrative: I have a cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (I have a cold) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (I have a cold). At the time of the report, NASOPHARYNGITIS (I have a cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.  Patient had cold on the scheduled day of second shot and he was asking if he should take second shot or not.
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test negative
Clinical narrative: Absence of antibodies to the virus in her blood; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Absence of antibodies to the virus in her blood) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 037B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Absence of antibodies to the virus in her blood). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Absence of antibodies to the virus in her blood) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No lab data was provided. No concomitant medication was provided. A patient who received both doses of the Moderna Covid-19 vaccine on 17-Mar-2021 the first one and on 12-Apr-2021 the second one called to report that after having a blood work last week to determine the presence of antibodies in her blood, the result showed that she did not have any anti-virus antibodies in her blood She consulted with her physician, and she suggested that both doses of the Moderna Covid-19 vaccine should be repeated. The patient was asking if a third and a fourth dose of the Moderna Covid-19 was describe in the Moderna guidelines. Best method of contact is by her email. Expiration date of both vaccines was not provided.